Megan Daly, MD
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade (NCT03474497) | Megan Daly, MD | 2019-05-20 |
| Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer (NCT02599454) | Megan Daly, MD | 2018-04-26 |
Track Megan Daly, MD automatically
Every clearance here is in the API, with alerts when new ones post.